• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤内 S100B+卵泡星状细胞的空间分布与促性腺激素肿瘤中 FSH 和 ERα 的增殖和表达有关。

Intratumoural spatial distribution of S100B + folliculostellate cells is associated with proliferation and expression of FSH and ERα in gonadotroph tumours.

机构信息

Inserm U1052, CNRS UMR5286, University Claude Bernard Lyon 1, Cancer Research Center of Lyon, Lyon, France.

Endocrinology Department, "C.I. Parhon" National Institute of Endocrinology, Bucharest, Romania.

出版信息

Acta Neuropathol Commun. 2022 Feb 9;10(1):18. doi: 10.1186/s40478-022-01321-y.

DOI:10.1186/s40478-022-01321-y
PMID:35139928
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8827287/
Abstract

Folliculostellate cells are S100B-expressing cells with numerous functions in the normal anterior pituitary. These cells have also been identified in pituitary neuroendocrine tumours (PitNETs), where their precise role remains elusive. Here, we aimed to build a refined cartography of S100B-expressing cells to characterise their interpatient and intratumoural spatial distribution, and to start identifying their potential functions in PitNETs. High-throughput histological analysis of S100B-stained tumour sections of 54 PitNETs revealed a significant decrease in S100B + cells in PitNETs compared to the normal anterior pituitary. A Ki67 index ≥ 3, a mitosis count > 2/10 per high power fields, and a proliferative status, were all associated with fewer S100B + cells in gonadotroph tumours. Gonadotroph tumours also showed interpatient and intratumoural heterogeneity in the spatial distribution of S100B + cells. The existence of an intratumoural heterogeneity was further confirmed by the incorporation to our spatial analysis of additional markers: Ki67, FSH, LH, ERα and SSTR2. The tumour areas with fewer S100B + cells displayed a higher percentage of Ki67 + cells, whereas strong positive correlations were observed between S100B + , FSH + , and ERα + cells. Such spatial associations suggest that S100B + folliculostellate cells could play a role in gonadotroph tumorigenesis, and may contribute to the maintenance of tumour cells in a low proliferating, FSH + /ERα + differentiated state. Albeit, further in-depth functional studies are required to decipher the mechanisms underlying these spatial associations and to potentially identify a therapeutic use.

摘要

卵泡细胞是 S100B 表达细胞,在正常垂体前叶中具有多种功能。这些细胞也在垂体神经内分泌肿瘤(PitNETs)中被识别出来,但它们的确切作用仍然难以捉摸。在这里,我们旨在构建 S100B 表达细胞的精细化图谱,以描述它们在患者间和肿瘤内的空间分布,并开始识别它们在 PitNETs 中的潜在功能。对 54 例 PitNET 肿瘤组织中 S100B 染色切片进行高通量组织学分析,结果显示 PitNETs 中 S100B+细胞明显减少。Ki67 指数≥3、有丝分裂计数>2/10 高倍视野、增殖状态与促性腺激素肿瘤中 S100B+细胞数量减少有关。促性腺激素肿瘤在 S100B+细胞的空间分布上也存在患者间和肿瘤内的异质性。通过将额外的标记物(Ki67、FSH、LH、ERα 和 SSTR2)纳入我们的空间分析,进一步证实了肿瘤内异质性的存在。S100B+细胞较少的肿瘤区域显示出更高比例的 Ki67+细胞,而 S100B+、FSH+和 ERα+细胞之间观察到强烈的正相关。这种空间关联表明,S100B+卵泡细胞可能在促性腺激素肿瘤发生中发挥作用,并可能有助于维持肿瘤细胞处于低增殖、FSH+/ERα+分化状态。尽管如此,需要进一步的深入功能研究来阐明这些空间关联的机制,并有可能确定其治疗用途。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d828/8827287/7bda1ffe8444/40478_2022_1321_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d828/8827287/d238007025b3/40478_2022_1321_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d828/8827287/a6d893cff86c/40478_2022_1321_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d828/8827287/830d672bb41c/40478_2022_1321_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d828/8827287/9b2c289e142e/40478_2022_1321_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d828/8827287/d87c43cacc16/40478_2022_1321_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d828/8827287/7bda1ffe8444/40478_2022_1321_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d828/8827287/d238007025b3/40478_2022_1321_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d828/8827287/a6d893cff86c/40478_2022_1321_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d828/8827287/830d672bb41c/40478_2022_1321_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d828/8827287/9b2c289e142e/40478_2022_1321_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d828/8827287/d87c43cacc16/40478_2022_1321_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d828/8827287/7bda1ffe8444/40478_2022_1321_Fig6_HTML.jpg

相似文献

1
Intratumoural spatial distribution of S100B + folliculostellate cells is associated with proliferation and expression of FSH and ERα in gonadotroph tumours.肿瘤内 S100B+卵泡星状细胞的空间分布与促性腺激素肿瘤中 FSH 和 ERα 的增殖和表达有关。
Acta Neuropathol Commun. 2022 Feb 9;10(1):18. doi: 10.1186/s40478-022-01321-y.
2
FSH Levels Are Related to E-cadherin Expression and Subcellular Location in Nonfunctioning Pituitary Tumors.促卵泡激素水平与无功能性垂体瘤中 E-钙黏蛋白的表达和亚细胞定位有关。
J Clin Endocrinol Metab. 2020 Aug 1;105(8):2587-94. doi: 10.1210/clinem/dgaa281.
3
TGFBR3L is associated with gonadotropin production in non-functioning gonadotroph pituitary neuroendocrine tumours.TGFBR3L 与无功能促性腺激素细胞性垂体神经内分泌肿瘤中的促性腺激素分泌有关。
Pituitary. 2023 Apr;26(2):227-236. doi: 10.1007/s11102-023-01310-x. Epub 2023 Mar 23.
4
Gonadotroph adenoma with secondary hypersecretion of testosterone.促性腺激素腺瘤伴睾丸酮的继发性分泌过多。
World Neurosurg. 2013 Dec;80(6):900.e7-11. doi: 10.1016/j.wneu.2012.11.069. Epub 2012 Nov 28.
5
Immune Landscape of Pituitary Tumors Reveals Association Between Macrophages and Gonadotroph Tumor Invasion.垂体瘤的免疫景观揭示了巨噬细胞与促性腺细胞瘤侵袭之间的关联。
J Clin Endocrinol Metab. 2020 Nov 1;105(11). doi: 10.1210/clinem/dgaa520.
6
Chemokines modulate the tumour microenvironment in pituitary neuroendocrine tumours.趋化因子调节垂体神经内分泌肿瘤的肿瘤微环境。
Acta Neuropathol Commun. 2019 Nov 8;7(1):172. doi: 10.1186/s40478-019-0830-3.
7
Inhibition of activin signalling reduces the growth of LβT2 gonadotroph pituitary tumours in mouse.抑制激活素信号传导可减少小鼠LβT2促性腺激素垂体瘤的生长。
Endocr Relat Cancer. 2023 Feb 3;30(3). doi: 10.1530/ERC-22-0245. Print 2023 Mar 1.
8
Follicular cells in pituitary neuroendocrine tumors.垂体神经内分泌肿瘤中的滤泡细胞。
Hum Pathol. 2021 Aug;114:1-8. doi: 10.1016/j.humpath.2021.05.002. Epub 2021 May 12.
9
The expression of neural cell adhesion molecule and the microenvironment of pituitary neuroendocrine tumours.神经细胞黏附分子的表达与垂体神经内分泌肿瘤的微环境
J Neuroendocrinol. 2021 Dec;33(12):e13052. doi: 10.1111/jne.13052. Epub 2021 Oct 27.
10
Synchronous Multiple Pituitary Neuroendocrine Tumors of Different Cell Lineages.同步发生的不同细胞谱系的垂体神经内分泌肿瘤。
Endocr Pathol. 2018 Dec;29(4):332-338. doi: 10.1007/s12022-018-9545-4.

引用本文的文献

1
Factors Influencing Hormone Remission in Growth Hormone-Secreting Pituitary Neuroendocrine Tumors With Residual Tumor: A Retrospective Cohort Study.影响伴有残留肿瘤的生长激素分泌型垂体神经内分泌肿瘤激素缓解的因素:一项回顾性队列研究
CNS Neurosci Ther. 2025 Aug;31(8):e70574. doi: 10.1111/cns.70574.
2
A Nexus of Biomolecular Complexities in Pituitary Neuroendocrine Tumors: Insights into Key Molecular Drivers.垂体神经内分泌肿瘤中生物分子复杂性的关联:对关键分子驱动因素的见解
Biomedicines. 2025 Apr 16;13(4):968. doi: 10.3390/biomedicines13040968.
3
New insights in cellular senescence: The pituitary model.

本文引用的文献

1
Aggressive pituitary tumours and pituitary carcinomas.侵袭性垂体肿瘤和垂体癌。
Nat Rev Endocrinol. 2021 Nov;17(11):671-684. doi: 10.1038/s41574-021-00550-w. Epub 2021 Sep 7.
2
Follicular cells in pituitary neuroendocrine tumors.垂体神经内分泌肿瘤中的滤泡细胞。
Hum Pathol. 2021 Aug;114:1-8. doi: 10.1016/j.humpath.2021.05.002. Epub 2021 May 12.
3
Gonadotroph tumours with a low SF-1 labelling index are more likely to recur and are associated with enrichment of the PI3K-AKT pathway.SF-1 低标记指数的促性腺细胞瘤更有可能复发,并与 PI3K-AKT 通路的富集有关。
细胞衰老的新见解:垂体模型。
J Neuroendocrinol. 2025 May;37(5):e70008. doi: 10.1111/jne.70008. Epub 2025 Mar 3.
4
Prognostic Biomarkers in Pituitary Tumours: A Systematic Review.垂体肿瘤的预后生物标志物:一项系统综述
touchREV Endocrinol. 2023 Nov;19(2):42-53. doi: 10.17925/EE.2023.19.2.12. Epub 2023 Aug 9.
5
Aggressive PitNETs and Potential Target Therapies: A Systematic Review of Molecular and Genetic Pathways.侵袭性 PitNETs 及潜在的靶向治疗:分子和遗传途径的系统综述。
Int J Mol Sci. 2023 Oct 29;24(21):15719. doi: 10.3390/ijms242115719.
6
Role of Tumor Microenvironment in Pituitary Neuroendocrine Tumors: New Approaches in Classification, Diagnosis and Therapy.肿瘤微环境在垂体神经内分泌肿瘤中的作用:分类、诊断和治疗的新方法
Cancers (Basel). 2023 Nov 6;15(21):5301. doi: 10.3390/cancers15215301.
7
Tumour microenvironment and pituitary tumour behaviour.肿瘤微环境与垂体肿瘤行为
J Endocrinol Invest. 2023 Jun;46(6):1047-1063. doi: 10.1007/s40618-023-02089-1. Epub 2023 Apr 15.
Neuropathol Appl Neurobiol. 2021 Apr;47(3):415-427. doi: 10.1111/nan.12675. Epub 2020 Dec 20.
4
Treatment Options for Gonadotroph Tumors: Current State and Perspectives.促性腺激素肿瘤的治疗选择:现状与展望。
J Clin Endocrinol Metab. 2020 Oct 1;105(10). doi: 10.1210/clinem/dgaa497.
5
The tumour microenvironment of pituitary neuroendocrine tumours.垂体神经内分泌肿瘤的肿瘤微环境。
Front Neuroendocrinol. 2020 Jul;58:100852. doi: 10.1016/j.yfrne.2020.100852. Epub 2020 Jun 15.
6
FSH Levels Are Related to E-cadherin Expression and Subcellular Location in Nonfunctioning Pituitary Tumors.促卵泡激素水平与无功能性垂体瘤中 E-钙黏蛋白的表达和亚细胞定位有关。
J Clin Endocrinol Metab. 2020 Aug 1;105(8):2587-94. doi: 10.1210/clinem/dgaa281.
7
Gonadotroph Tumors Show Subtype Differences That Might Have Implications for Therapy.促性腺激素瘤显示出亚型差异,这可能对治疗有影响。
Cancers (Basel). 2020 Apr 20;12(4):1012. doi: 10.3390/cancers12041012.
8
Pituitary-Tumor Endocrinopathies.垂体肿瘤内分泌病
N Engl J Med. 2020 Mar 5;382(10):937-950. doi: 10.1056/NEJMra1810772.
9
Pangenomic Classification of Pituitary Neuroendocrine Tumors.基于泛基因组的垂体神经内分泌肿瘤分类。
Cancer Cell. 2020 Jan 13;37(1):123-134.e5. doi: 10.1016/j.ccell.2019.11.002. Epub 2019 Dec 26.
10
The Microenvironment of Pituitary Tumors-Biological and Therapeutic Implications.垂体肿瘤的微环境——生物学及治疗意义
Cancers (Basel). 2019 Oct 21;11(10):1605. doi: 10.3390/cancers11101605.